Shekhar_2008_Am.J.Psychiatry_165_1033

Reference

Title : Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia - Shekhar_2008_Am.J.Psychiatry_165_1033
Author(s) : Shekhar A , Potter WZ , Lightfoot J , Lienemann J , Dube S , Mallinckrodt C , Bymaster FP , McKinzie DL , Felder CC
Ref : Am J Psychiatry , 165 :1033 , 2008
Abstract : Shekhar_2008_Am.J.Psychiatry_165_1033
ESTHER : Shekhar_2008_Am.J.Psychiatry_165_1033
PubMedSearch : Shekhar_2008_Am.J.Psychiatry_165_1033
PubMedID: 18593778

Related information

Citations formats

Shekhar A, Potter WZ, Lightfoot J, Lienemann J, Dube S, Mallinckrodt C, Bymaster FP, McKinzie DL, Felder CC (2008)
Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia
Am J Psychiatry 165 :1033

Shekhar A, Potter WZ, Lightfoot J, Lienemann J, Dube S, Mallinckrodt C, Bymaster FP, McKinzie DL, Felder CC (2008)
Am J Psychiatry 165 :1033